Cargando…
Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway
Huntington disease (HD) is a brain disorder characterized by the late onset of motor and cognitive symptoms, even though the neurons in the brain begin to suffer dysfunction and degeneration long before symptoms appear. There is currently no cure. Several molecular and developmental effects of HD ha...
Autores principales: | Szlachcic, Wojciech J., Switonski, Pawel M., Krzyzosiak, Wlodzimierz J., Figlerowicz, Marek, Figiel, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582098/ https://www.ncbi.nlm.nih.gov/pubmed/26092128 http://dx.doi.org/10.1242/dmm.019406 |
Ejemplares similares
-
Mouse Models of Polyglutamine Diseases: Review and Data Table. Part I
por: Figiel, Maciej, et al.
Publicado: (2012) -
Mouse Models of Polyglutamine Diseases in Therapeutic Approaches: Review and Data Table. Part II
por: Switonski, Pawel M., et al.
Publicado: (2012) -
The Generation of Mouse and Human Huntington Disease iPS Cells Suitable for In vitro Studies on Huntingtin Function
por: Szlachcic, Wojciech J., et al.
Publicado: (2017) -
Corrigendum: The Generation of Mouse and Human Huntington Disease iPS Cells Suitable for In vitro Studies on Huntingtin Function
por: Szlachcic, Wojciech J., et al.
Publicado: (2017) -
Huntington Disease as a Neurodevelopmental Disorder and Early Signs of the Disease in Stem Cells
por: Wiatr, Kalina, et al.
Publicado: (2017)